The Testosterone Myth That’s Costing Men Years of Their Lives | Ep 299 with Shalin Shah CEO of Marius Pharmaceuticals

Shalin Shah joins Founder’s Story to explain why declining testosterone levels represent a global health crisis and how outdated myths, regulations, and delivery methods have held back effective treatment. He shares the science behind testosterone as a core metabolic hormone, the FDA approval of KYZATREX, and why oral therapy marks a paradigm shift in how men (and women) can age healthier, longer lives.

Key Discussion Points:
Shalin explains how testosterone sits at the foundation of metabolic health, influencing the brain, heart, muscle, bone, and even cellular energy. He breaks down the biggest myths around testosterone, including fears about heart attacks and prostate cancer, and explains why modern clinical data has disproven them. The conversation also explores why injections fail to match the body’s natural hormone rhythm and how oral therapy better mirrors daily physiology. Finally, Shalin discusses why consumer-driven healthcare and telemedicine are accelerating access to testing and treatment.

Takeaways:
This episode reframes testosterone replacement therapy as a legitimate, evidence-backed medical intervention rather than a stigmatized shortcut. Shalin emphasizes that testing is the first step, education is critical, and hormonal health must be layered on top of sleep, diet, stress management, and exercise. His core message is clear: testosterone therapy isn’t about chasing youth, it’s about restoring health, vitality, and longevity.

Closing Thoughts:
Shalin Shah’s perspective challenges decades of misinformation and positions testosterone as one of the most powerful biomarkers of overall health. This conversation invites listeners to rethink aging, advocate for better testing, and consider how modern medicine can help add life to years, not just years to life.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.